Tag: first-line treatment
-
GSK Plans First-Line Jideytro Filing After 94% Response Rate
GSK plans to seek first-line FDA approval for Jideytro after the ROS1 inhibitor achieved a 94% response rate in 94 TKI-naïve patients in the ARROS-1 study.
-
Bayer’s Hyrnuo Wins First-Line FDA Approval in HER2-Mutant Lung Cancer
The FDA granted Bayer’s Hyrnuo accelerated approval as a first-line treatment for HER2-mutant non-small cell lung cancer after the oral therapy achieved a 75% response rate in SOHO-01.